04.03.2013 Views

Anesthesia Student Survival Guide.pdf - Index of

Anesthesia Student Survival Guide.pdf - Index of

Anesthesia Student Survival Guide.pdf - Index of

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

72 ● AnesthesiA student survivAl <strong>Guide</strong><br />

the low pH and metabisulfite preservative in the solutions used. Plain,<br />

preservative-free 2-chloroprocaine in appropriate intrathecal doses<br />

appears to be no more neurotoxic than other commonly used spinal<br />

anesthetic solutions, and it may carry a reduced risk <strong>of</strong> TNS (see below).<br />

Transient neurologic symptoms (TNS): Patients receiving spinal anesthesia<br />

may have transient hypesthesias, paresthesias, and motor weakness in<br />

the legs or buttocks. TNS is significantly more common with lidocaine<br />

than with bupivacaine or tetracaine (and likely 2-chloroprocaine). TNS<br />

symptoms typically resolve within 3 days, but occasionally may persist<br />

for as long as 6 months.<br />

● Methemoglobinemia: Larger doses <strong>of</strong> prilocaine and benzocaine (a common<br />

ingredient in local anesthetic sprays) can convert hemoglobin to methemoglobin.<br />

Infusion <strong>of</strong> 1–2 mg/kg <strong>of</strong> methylene blue reverses this reaction.<br />

● Hypersensitivity/Allergy: While an adverse reaction to a local anesthetic<br />

is not uncommon, a true allergy is exceedingly rare. Allergic reactions are<br />

most <strong>of</strong>ten associated with esters because <strong>of</strong> sensitivity to their metabolite,<br />

para-aminobenzoic acid (PABA). Should this occur, consider switching to<br />

an amide anesthetic.<br />

Treatment <strong>of</strong> Local Anesthetic Toxicity<br />

Infusion <strong>of</strong> 20% lipid emulsion solution (such as Intralipid) has been reported to<br />

be effective in reversing the symptoms <strong>of</strong> local anesthetic toxicity. The presumed<br />

mechanism <strong>of</strong> action is that the lipid-soluble fraction <strong>of</strong> the local anesthetic<br />

is sequestered in the lipid emulsion and effectively removed from the plasma.<br />

Although this treatment is still being investigated, the following treatment<br />

protocol has been proposed (see www.lipidrescue.org):<br />

●<br />

●<br />

●<br />

Bolus 1.5 mL/kg <strong>of</strong> 20% lipid emulsion, then run 0.25 mL/kg/min for<br />

30–60 min.<br />

Repeat the bolus dose for persistent asystole.<br />

Increase the infusion rate for hypotension.<br />

Case Study<br />

A 70 kg otherwise healthy male patient is undergoing bilateral inguinal<br />

herniorrhaphy under local anesthesia administered by the surgeon and intravenous<br />

sedation you are giving. The surgeon is planning to infiltrate the skin<br />

with lidocaine prior to skin incision.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!